GMG-2 polynucleotides and polypeptides and uses thereof

Details for Australian Patent Application No. 2002321768 (hide)

Owner Serono Genetics Institute S.A.

Inventors Tanaka, Hiroaki; Dialynas, Deno; Scalia, Aaron; Lucas, John

Agent Griffith Hack

Pub. Number AU-B-2002321768

PCT Number PCT/IB02/03407

PCT Pub. Number WO2003/010314

Priority 60/308,253 26.07.01 US; 60/315,277 27.08.01 US; 60/309,210 31.07.01 US

Filing date 25 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 6 March 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/308,253 26.07.01 US; 60/315,277 27.08.01 US; 60/309,210 31.07.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002321768

23 December 2004 Change of Name(s) of Applicant(s), Section 104

  Genset S.A. The name of the applicant has been changed to Serono Genetics Institute S.A. Change of Name(s) of Applicant(s), Section 104

6 March 2008 Application Accepted

  Published as AU-B-2002321768

3 July 2008 Standard Patent Sealed

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002321769-AGONISTS AND ANTAGONISTS OF COBESIN FOR THE TREATMENT OF METABOLIC DISORDERS

2002321767-TR XIDATIN AGONISTS AND ANTAGONISTS TREATMENT OF METABOLIC DISORDERS